Cavo M; Brioli A; Tacchetti P; Zannetti BA; Mancuso K; Zamagni E., Role of consolidation therapy in transplant eligible multiple myeloma patients., «SEMINARS IN ONCOLOGY», 2013, 40, pp. 610 - 617 [articolo]
Borsi, E; Perrone, G; Terragna, C; Martello, M; Mancini, M; Leo, E; Zamagni, E; Tacchetti, P; Brioli, A; Pantani, L; Zannetti, B; Martinelli, G; Cavo, M, SIRT regulates the molecular interaction between c-MYC and HIF-1 alpha in multiple myeloma, in: CANCER RESEARCH, 2013, pp. 3415 - 3415 (atti di: 104th Annual Meeting of the American-Association-for-Cancer-Research (AACR), Washington, DC, APR 06-10, 2013) [atti di convegno-abstract]
Nanni C; Zamagni E; Celli M; Caroli P; Ambrosini V; Tacchetti P; Brioli A; Zannetti B; Pezzi A; Pantani L; Perrone G; Zompatori M; Cavo M; Colletti PM; Rubello D; Fanti S., The Value of 18F-FDG PET/CT after Autologous Stem Cell Transplantation (ASCT) in Patients Affected by Multiple Myeloma (MM): Experience With 77 Patients, «CLINICAL NUCLEAR MEDICINE», 2013, 38, pp. e74 - e79 [articolo]
Simona Soverini, Caterina De Benedittis, Katerina Machova Polakova, Adela Brouckova, Fausto Castagnetti, Gabriele Gugliotta, Francesca Palandri, Cristina Papayannidis, Ilaria Iacobucci, Claudia Venturi, Manuela Mancini, Elisa Leo, Hana Klamova, Stefania Paolini, Domenico Russo, Gianantonio Rosti, Michele Baccarani, Michele Cavo, Giovanni Martinelli, Ultra Deep Sequencing (UDS) Allows More Sensitive Detection Of Tyrosine Kinase Inhibitor (TKI)-Resistant BCR-ABL Mutations That Would Influence Therapeutic Decision At The Time Of Switchover To Second- Or Third-Line Therapy, «BLOOD», 2013, 122, pp. 380 - 380 [abstract]
Soverini S; De Benedittis C; Machova Polakova K; Brouckova A; Horner D; Iacono M; Castagnetti F; Gugliotta G; Palandri F; Papayannidis C; Iacobucci I; Venturi C; Bochicchio MT; Klamova H; Cattina F; Russo D; Bresciani P; Binotto G; Giannini B; Kohlmann A; Haferlach T; Roller A; Rosti G; Cavo M; Baccarani M; Martinelli G., Unraveling the complexity of tyrosine kinase inhibitor-resistant populations by ultra-deep sequencing of the BCR-ABL kinase domain., «BLOOD», 2013, 122, pp. 1634 - 1648 [articolo]
Larocca A; Cavallo F; Bringhen S; Di Raimondo F; Falanga A; Evangelista A; Cavalli M; Stanevsky A; Corradini P; Pezzatti S; Patriarca F; Cavo M; Peccatori J; Catalano L; Carella AM; Cafro AM; Siniscalchi A; Crippa C; Petrucci MT; Yehuda DB; Beggiato E; Di Toritto TC; Boccadoro M; Nagler A; Palumbo A., Aspirin or enoxaparin thromboprophylaxis for patients with newly diagnosed multiple myeloma treated with lenalidomide., «BLOOD», 2012, 119, pp. 933 - 939 [articolo]
Cavo M; Pantani L; Petrucci MT; Patriarca F; Zamagni E; Donnarumma D; Crippa C; Boccadoro M; Perrone G; Falcone A; Nozzoli C; Zambello R; Masini L; Furlan A; Brioli A; Derudas D; Ballanti S; Dessanti ML; De Stefano V; Carella AM; Marcatti M; Nozza A; Ferrara F; Callea V; Califano C; Pezzi A; Baraldi A; Grasso M; Musto P; Palumbo A., Bortezomib-thalidomide-dexamethasone is superior to thalidomide-dexamethasone as consolidation therapy following autologous hematopoietic stem-cell transplantation in patients with newly diagnosed multiple myeloma., «BLOOD», 2012, 120, pp. 9 - 19 [articolo]
Palumbo A; Hajek R; Delforge M; Kropff M; Petrucci MT; Catalano J; Gisslinger H; Wiktor-Jędrzejczak W; Zodelava M; Weisel K; Cascavilla N; Iosava G; Cavo M; Kloczko J; Bladé J; Beksac M; Spicka I; Plesner T; Radke J; Langer C; Ben Yehuda D; Corso A; Herbein L; Yu Z; Mei J; Jacques C; Dimopoulos MA; MM-015 Investigators., Continuous lenalidomide treatment for newly diagnosed multiple myeloma., «THE NEW ENGLAND JOURNAL OF MEDICINE», 2012, 366, pp. 1759 - 1789 [articolo]
P. Spinnato; A. Bazzocchi; A. Brioli; C. Nanni; E. Zamagni; U. Albisinni; M. Cavo; S. Fanti; G. Battista; E. Salizzoni, Contrast enhanced MRI and (18)F-FDG PET-CT in the assessment of multiple myeloma: a comparison of results in different phases of the disease, «EUROPEAN JOURNAL OF RADIOLOGY», 2012, 81, pp. 4013 - 4018 [articolo]
Ludwig H; Avet-Loiseau H; Bladé J; Boccadoro M; Cavenagh J; Cavo M; Davies F; de la Rubia J; Delimpasi S; Dimopoulos M; Drach J; Einsele H; Facon T; Goldschmidt H; Hess U; Mellqvist UH; Moreau P; San-Miguel J; Sondergeld P; Sonneveld P; Udvardy M; Palumbo A., European perspective on multiple myeloma treatment strategies: update following recent congresses., «THE ONCOLOGIST», 2012, 17, pp. 592 - 606 [articolo]
Alessandro Gozzetti; Alfonso Cerase; Flavia Lotti; Davide Rossi; Antonio Palumbo; Maria Teresa Petrucci; Francesca Patriarca; Chiara Nozzoli; Michele Cavo; Massimo Offidani; Michele Floridia; Salvatore Berretta; Roberto Vallone; Pellegrino Musto; Francesco Lauria; and for the GIMEMA (Gruppo Italiano Malattie Ematologiche dell'Adulto) Myeloma Working Party; additional authors who participated to the study: Elena Marchini; Alberto Fabbri; Stefania Oliva; Elena Zamagni; Fabiana Gentilini; Stelvio Ballanti; Giuseppe Mele; Monica Galli; Maria Teresa Pirrotta; Francesco Di Raimondo, Extramedullary intracranial localization of multiple myeloma and treatment with novel agents: a retrospective survey of 50 patients, «CANCER», 2012, 118, pp. 1574 - 1584 [articolo]
Terragna, C; Martello, M; Martinelli, G; Durante, S; Pantani, L; Zamagni, E; Tacchetti, P; Brioli, A; Perrone, G; Zannetti, Ba; Borsi, E; Biasco, G; Baccarani, M; Cavo, M., Gene expression analysis of newly diagnosed Multiple Myeloma (MM) patients carrying amplified MDM4 and/or deleted p5, in: Suppl. 1, Chicago, «CANCER RESEARCH», 2012, 72, pp. 1873 - 1873 (atti di: AACR 2012 Annual Meeting, Chicago, 30 March - 04 April 2012) [atti di convegno-abstract]
G Perrone; E Borsi; C Terragna; M Martello; M Mancini; M Aluigi; MA Santucci; G Martinelli; M Baccarani; M Cavo, HIF-1a INHIBITION PROMOTES CELL CYCLE ARREST IN MULTIPLE MYELOMA, in: s1, «HAEMATOLOGICA», 2012, 97, pp. 105 - 105 (atti di: 17th Congress of the European Hematology Association, Amsterdam, The Netherlands, June 14 – 17, 2012) [atti di convegno-abstract]
Terragna C; Martello M; Pantani L; Patriarca F; Zamagni E; Galli M; Tacchetti P; Petrucci MT; Crippa C; Bringhen S; Brioli A; Offidani M; Perrone G; Zannetti BA; Borsi E; Testoni N; Marzocchi G; Baccarani M; Martinelli G; Cavo M., High CNA level and over-expression of genes involved in response mechanisms to genotoxic stress characterize newly diagnosed Multiple Myeloma (MM) patients carrying amplified MDM4 and/or deleted TP53, in: s1, «HAEMATOLOGICA», 2012, 97, pp. 240 - 240 (atti di: 17th Congress of the European Hematology Association, Amsterdam, The Netherlands, June 14 – 17, 2012) [atti di convegno-abstract]
Ludwig H, Durie BG, McCarthy P, Palumbo A, San Miguel J, Barlogie B, Morgan G, Sonneveld P, Spencer A, Andersen KC, Facon T, Stewart KA, Einsele H, Mateos MV, Wijermans P, Waage A, Beksac M, Richardson PG, Hulin C, Niesvizky R, Lokhorst H, Landgren O, Bergsagel PL, Orlowski R, Hinke A, Cavo M, Attal M; International Myeloma Working Group., IMWG consensus on maintenance therapy in multiple myeloma., «BLOOD», 2012, 119, pp. 3003 - 3015 [articolo]
